If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPTY.L Regulatory News (PTY)

  • There is currently no data for PTY

Director/PDMR Shareholding - Options Grant

25 Nov 2020 07:00

RNS Number : 3734G
Parity Group PLC
25 November 2020
Β 

25 November 2020

Β 

Parity Group plc ("Parity" or the "Company")

Grant of Options to Directors/PDMRs

Β 

The Board of Parity (AIM:PTY), the technology focussed professional services business, announces that it has awarded Michael Johns, Chief Financial Officer, options over 2,000,000 ordinary shares of 2 pence each in the Company ("the Share Options"). The Share Options were granted on 24 November 2020 and represent approximately 1.9% of the Company's current issued share capital.

Β 

The Share Options each have an exercise price, calculated in accordance with the rules of the Parity Group 2019 EMI Options Plan, of 7.88 pence, being the closing mid-market price per ordinary share on 23 November 2020.

Β 

The Share Options will vest after 3 years and are subject to the following performance conditions:

Β 

Β· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 12.0 pence for a period of at least five consecutive trading days at any time during the vesting period;

Β· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 15.0 pence for a period of at least five consecutive trading days at any time during the vesting period; and

Β· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 18.0 pence for a period of at least five consecutive trading days at any time during the vesting period.

Β 

Β 

Β 

Contacts:

Parity Group plc www.parity.net

Matthew Bayfield, CEO 0208 171 1729

Β 

WH Ireland Limited www.whirelandcb.com

Mike Coe / Chris Savidge 0207 220 1666

Β 

Donhead Consultants

David Beck +44 7836 293383

Β 

Β 

Β 

Β 

Β 

Β 

The notifications below, made in accordance with the EU Market Abuse Regulation, provide further details in relation to the grant of the Share Options to the PDMRs:

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Michael Johns

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β 

Parity Group plc

b)

Β 

LEI

213800YEHAYBJ63OHB38

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary shares of 2p each

Β 

GB00B1235860

b)

Β 

Nature of the transaction

Β 

Grant of options to subscribe for new ordinary shares under the Company's 2019 EMI Option Plan.

c)

Β 

Price(s) and volume(s)

Β 

Option Price(s)

Β 

Volume(s)

7.88p

2,000,000

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

2,000,000

Β 

Β£157,600.00

Β 

e)

Β 

Date of the transaction

24 November 2020

f)

Β 

Place of the transaction

Outside a trading venue

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPPGQWGUPUGAC
Date   Source Headline
20th Jul 200512:06 pmRNSDirector/PDMR Shareholding
6th Jul 20056:02 pmRNSDirector/PDMR Shareholding
4th Jul 200510:00 amRNSDirector/PDMR Shareholding
30th Jun 20056:02 amPRNContract Wins
30th Jun 20056:01 amPRNBoard Changes
30th Jun 20056:00 amPRNAGM Statement
5th May 20056:00 amPRNDirector Declaration
19th Apr 20057:01 amRNSFinal Results
6th Apr 20056:00 amPRNNotice of Results
23rd Mar 20053:20 pmPRNNotice of Results
9th Mar 200510:05 amPRNNotice of Results
11th Feb 20051:19 pmRNSHolding(s) in Company
7th Feb 20052:26 pmRNSHolding(s) in Company
20th Jan 20057:00 amPRNTrading Update
5th Jan 200512:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.